BIT
TARA icon

BlackRock Institutional Trust’s Protara Therapeutics TARA Stock Holding History

BlackRock Institutional Trust’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,286
Closed -$398K – 3947
2016
Q1 		$398K Sell
1,286
-19
-1% -$6.12K ﹤0.01% 3507
2015
Q4 		$810K Buy
1,305
+48
+4% +$28.2K ﹤0.01% 3384
2015
Q3 		$700K Buy
1,257
+194
+18% +$120K ﹤0.01% 3430
2015
Q2 		$759K Buy
+1,063
New +$658K ﹤0.01% 3424

Other funds holding TARA

TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

BlackRock Institutional Trust's TARA Position: Q2 2016 in Review

BlackRock Institutional Trust sold out of Protara Therapeutics (TARA) in Q2 2016, closing a stake of 1,286 shares — an estimated $398K sold.

BlackRock Institutional Trust first reported a position in TARA in Q2 2015 and held it in 4 quarters. The position peaked at $810K in Q4 2015. 32 funds tracked by Wall St. Rank hold TARA as of Q2 2016.

  • BlackRock Institutional Trust reported no remaining Protara Therapeutics position as of Q2 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 1,286 Protara Therapeutics shares in Q2 2016, an estimated $398K.
  • BlackRock Institutional Trust first reported a position in Protara Therapeutics in Q2 2015 and held it in 4 quarters.
  • BlackRock Institutional Trust's Protara Therapeutics position peaked at $810K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2016.

Based on BlackRock Institutional Trust's 13F filing for Q2 2016, filed 10 Aug 2016.